Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | GD2 CAR T cells |
Synonyms | |
Therapy Description |
GD2 CAR T cells are T cells that have been engineered to express a chimeric antigen receptor (CAR) that targets the disialoganglioside GD2, potentially resulting in increased death of GD2-expressing tumor cells (PMID: 29662203). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
GD2 CAR T cells | GD2 CAR T cells are T cells that have been engineered to express a chimeric antigen receptor (CAR) that targets the disialoganglioside GD2, potentially resulting in increased death of GD2-expressing tumor cells (PMID: 29662203). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT05544526 | Phase I | GD2 CAR T cells | CAR T Cells to Target GD2 for DMG (CARMIGO) | Recruiting | GBR | 0 |
NCT04196413 | Phase I | Cyclophosphamide + Fludarabine GD2 CAR T cells | GD2 CAR T Cells in Diffuse Intrinsic Pontine Gliomas(DIPG) & Spinal Diffuse Midline Glioma(DMG) | Recruiting | USA | 0 |
NCT05990751 | Phase I | GD2 CAR T cells | Multi-modular Chimeric Antigen Receptor Targeting GD2 in Neuroblastoma (MAGNETO) | Recruiting | GBR | 0 |